XML 48 R36.htm IDEA: XBRL DOCUMENT v3.25.2
BUSINESS COMBINATION (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Feb. 14, 2024
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Common stock, shares outstanding 164,614,418 193,693,433     193,693,433   177,991,365
Merger transaction costs $ 7,728,681   $ 7,499,353  
Transaction costs charged to equity 229,328            
Issuance of Series B preferred stock $ 3,613,000   $ 3,613,000      
Earnout Shares [Member]              
Earnout shares issuable 24,500,000            
Tevogen Bio [Member]              
Ownership percentage 91.00%